Cargando…

Coopetition in quantum prisoner’s dilemma and COVID-19

Decision-making is important especially during a crisis such as the novel COVID-19 pandemic. The quantum prisoner’s dilemma with two dilemma strength parameters is introduced as a model for the interaction between pharmaceutical and other related enterprises during the pandemic. Novel Nash equilibri...

Descripción completa

Detalles Bibliográficos
Autor principal: Elgazzar, Ahmed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943713/
https://www.ncbi.nlm.nih.gov/pubmed/33716597
http://dx.doi.org/10.1007/s11128-021-03054-8
_version_ 1783662548295352320
author Elgazzar, Ahmed S.
author_facet Elgazzar, Ahmed S.
author_sort Elgazzar, Ahmed S.
collection PubMed
description Decision-making is important especially during a crisis such as the novel COVID-19 pandemic. The quantum prisoner’s dilemma with two dilemma strength parameters is introduced as a model for the interaction between pharmaceutical and other related enterprises during the pandemic. Novel Nash equilibria are identified. The coopetition equilibrium (simultaneous cooperation and competition) is emphasized. Motivated by the novel equilibria of the quantum version, a classical mixed-strategy formulation that can be applied to real-world situations is proposed. Suitable values of the dilemma strength parameters and quantum entanglement can encourage coopetition, which can be considered as a route to full cooperation.
format Online
Article
Text
id pubmed-7943713
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79437132021-03-10 Coopetition in quantum prisoner’s dilemma and COVID-19 Elgazzar, Ahmed S. Quantum Inf Process Article Decision-making is important especially during a crisis such as the novel COVID-19 pandemic. The quantum prisoner’s dilemma with two dilemma strength parameters is introduced as a model for the interaction between pharmaceutical and other related enterprises during the pandemic. Novel Nash equilibria are identified. The coopetition equilibrium (simultaneous cooperation and competition) is emphasized. Motivated by the novel equilibria of the quantum version, a classical mixed-strategy formulation that can be applied to real-world situations is proposed. Suitable values of the dilemma strength parameters and quantum entanglement can encourage coopetition, which can be considered as a route to full cooperation. Springer US 2021-03-10 2021 /pmc/articles/PMC7943713/ /pubmed/33716597 http://dx.doi.org/10.1007/s11128-021-03054-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Elgazzar, Ahmed S.
Coopetition in quantum prisoner’s dilemma and COVID-19
title Coopetition in quantum prisoner’s dilemma and COVID-19
title_full Coopetition in quantum prisoner’s dilemma and COVID-19
title_fullStr Coopetition in quantum prisoner’s dilemma and COVID-19
title_full_unstemmed Coopetition in quantum prisoner’s dilemma and COVID-19
title_short Coopetition in quantum prisoner’s dilemma and COVID-19
title_sort coopetition in quantum prisoner’s dilemma and covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943713/
https://www.ncbi.nlm.nih.gov/pubmed/33716597
http://dx.doi.org/10.1007/s11128-021-03054-8
work_keys_str_mv AT elgazzarahmeds coopetitioninquantumprisonersdilemmaandcovid19